DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 157 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q2 2020. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $3,517,000 | -38.3% | 996,412 | 0.0% | 0.05% | -27.9% |
| Q4 2019 | $5,699,000 | +60.0% | 996,412 | 0.0% | 0.07% | +51.1% |
| Q3 2019 | $3,562,000 | -10.4% | 996,412 | 0.0% | 0.04% | -8.2% |
| Q2 2019 | $3,976,000 | +9.6% | 996,412 | +100.7% | 0.05% | +6.5% |
| Q1 2019 | $3,629,000 | -19.1% | 496,412 | +1.2% | 0.05% | -29.2% |
| Q4 2018 | $4,487,000 | -33.7% | 490,363 | -10.1% | 0.06% | -25.3% |
| Q3 2018 | $6,767,000 | -44.2% | 545,715 | -31.3% | 0.09% | -48.2% |
| Q2 2018 | $12,120,000 | -17.7% | 794,747 | +7.1% | 0.17% | -25.7% |
| Q1 2018 | $14,729,000 | +2.2% | 742,015 | -3.7% | 0.23% | +8.7% |
| Q4 2017 | $14,407,000 | -18.7% | 770,441 | -6.5% | 0.21% | -17.5% |
| Q3 2017 | $17,712,000 | +174.7% | 823,825 | +23.3% | 0.25% | +157.1% |
| Q2 2017 | $6,448,000 | +281.5% | 668,215 | +135.2% | 0.10% | +237.9% |
| Q1 2017 | $1,690,000 | +62.8% | 284,082 | +8.1% | 0.03% | +45.0% |
| Q4 2016 | $1,038,000 | -66.7% | 262,769 | -11.7% | 0.02% | -63.6% |
| Q3 2016 | $3,120,000 | +12.6% | 297,462 | +56.6% | 0.06% | +3.8% |
| Q2 2016 | $2,770,000 | -10.0% | 189,962 | +18.8% | 0.05% | -11.7% |
| Q1 2016 | $3,078,000 | -30.9% | 159,962 | -13.2% | 0.06% | -23.1% |
| Q4 2015 | $4,454,000 | -3.2% | 184,362 | -1.7% | 0.08% | +1.3% |
| Q3 2015 | $4,602,000 | -37.4% | 187,522 | -40.3% | 0.08% | +45.3% |
| Q2 2015 | $7,354,000 | +162.4% | 313,924 | +151.2% | 0.05% | +32.5% |
| Q1 2015 | $2,803,000 | +375.9% | 124,962 | +257.4% | 0.04% | +344.4% |
| Q4 2014 | $589,000 | – | 34,962 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 10,895,773 | $47,070,000 | 4.39% |
| DC Investments Management, LLC | 196,799 | $850,000 | 0.93% |
| Chicago Capital, LLC | 3,930,524 | $16,980,000 | 0.87% |
| PFM Health Sciences, LP | 2,936,990 | $12,688,000 | 0.59% |
| Avidity Partners Management LP | 2,025,000 | $8,748,000 | 0.41% |
| Soleus Capital Management, L.P. | 167,798 | $725,000 | 0.38% |
| Rhenman & Partners Asset Management AB | 925,534 | $3,998,000 | 0.36% |
| Haafor (Singapore) Pte. Ltd. | 27,128 | $117,000 | 0.24% |
| JACKSON SQUARE CAPITAL, LLC | 122,555 | $529,000 | 0.23% |
| Parkman Healthcare Partners LLC | 200,000 | $864,000 | 0.23% |